Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2024) 99 EP64 | DOI: 10.1530/endoabs.99.EP64

ECE2024 Eposter Presentations Diabetes, Obesity, Metabolism and Nutrition (383 abstracts)

Progressive hyperparathyroidism post simultaneous pancreas-kidney transplantation in a long-term type 1 diabetes mellitus remission patient

Alexandra Zueva 1,2


1Endocrinology Research Center, Moscow, Russian Federation; 2The University of Sheffield, Sheffield, United Kingdom


Background: Simultaneous pancreas-kidney transplantation is an effective intervention for selected patients with insulin-dependent diabetes and end-stage chronic kidney disease (CKD), offering freedom from dialysis, insulin injections, and daily blood glucose monitoring. However, limited data exists on the impact of CKD complications on patient survival post-transplantation.

Case Presentation: A 58-year-old woman with Type 1 Diabetes (T1D) diagnosed in 1987 at the age of 22, end-stage CKD diagnosed in 2006, who underwent simultaneous pancreas-kidney transplantation in 2014, presented to our clinic for an annual check-up. It was known from her medical history that the patient had developed multiple diabetic complications such as diabetic kidney disease, diabetic retinopathy, and diabetes-related foot disease as a result of poor early glycemic control. Additionally, severe osteoporosis has developed since 2010 due to secondary hyperparathyroidism (HPT), treated with denosumab and cinacalcet. In 2022, she was diagnosed with tertiary HPT based on ultrasound signs of parathyroid glands hyperplasia, a decrease of bone mineral density (BMD), and multiple vertebral fractures on X-ray, although surgical intervention was not pursued, and alfacalcidol was added. A primary laboratory survey performed in our clinic showed HbA1c at 6.4%, C-peptide at 1.95 ng/ml, and normoglycemia without insulin. Under this treatment, creatinine clearance measured 49 mL/min, PTH and corrected total serum calcium remained within the normal range. While both transplants function appeared satisfactory, BMD remained stable since 2022 without any improvement despite treatment. Ophthalmic examination revealed no progression of retinopathy. Considering the limited impact of nonsurgical HPT treatment on skeletal health, parathyroidectomy was recommended.

Conclusions: This case highlights a nine-year remission period following successful simultaneous pancreas-kidney transplantation in a T1D patient. However, it also underscores the progressive nature of complications post-transplantation, necessitating careful monitoring and timely intervention to prevent further complications.

Volume 99

26th European Congress of Endocrinology

Stockholm, Sweden
11 May 2024 - 14 May 2024

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.